Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add filters








Year range
1.
Mem. Inst. Oswaldo Cruz ; 108(supl.1): 74-79, 2013. tab, graf
Article in English | LILACS | ID: lil-697834

ABSTRACT

In this review, we analyse the impact of a population and evolutionary genetics approach on the study of insect behaviour. Our attention is focused on the model organism Drosophila melanogaster and several other insect species. In particular, we explore the relationship between rhythmic behaviours and the molecular evolution of clock and ion channel genes.


Subject(s)
Animals , Behavior, Animal/physiology , Circadian Clocks/genetics , Drosophila melanogaster/genetics , Evolution, Molecular , Genetics, Population , CLOCK Proteins/genetics , Drosophila/genetics , Genetic Speciation , Ion Channels/genetics , Period Circadian Proteins/genetics , Psychodidae/genetics , Sexual Behavior, Animal , Temperature , Transgenes/genetics
2.
Experimental & Molecular Medicine ; : 60-67, 2012.
Article in English | WPRIM | ID: wpr-211717

ABSTRACT

Anterior gradient-2 (AGR2) promotes tumor growth, cell migration, and cellular transformation, and is one of the specific mRNA markers for circulating tumor cells in patients with gastrointestinal cancer. We investigated the feasibility of AGR2 as a potent antigen for tumor immunotherapy against colorectal cancer (CRC) cells using dendritic cells (DCs) transduced with a recombinant adenovirus harboring the AGR2 gene (AdAGR2). DCs transduced with a recombinant adenovirus encoding the AGR2 gene (AdAGR2/DCs) were characterized. These genetically-modified DCs expressed AGR2 mRNA as well as AGR2 protein at a multiplicity of infection of 1,000 without any significant alterations in DC viability and cytokine secretion (IL-10 and IL-12p70) compared with unmodified DCs as a control. In addition, AdAGR2 transduction did not impair DC maturation, but enhanced expression of HLA-DR, CD80, and CD86. AdAGR2/DCs augmented the number of IFN-gamma-secreting T-cells and elicited potent AGR2-specific cytotoxic T lymphocytes capable of lysing AGR2-expressing CRC cell lines. These results suggest that AGR2 act as a potentially important antigen for immunotherapy against CRC in clinical applications.


Subject(s)
Humans , Adenoviridae , Antigen Presentation/genetics , Antigens, Neoplasm/immunology , Carcinoma/therapy , Cell Line, Tumor , Colorectal Neoplasms/therapy , Cytotoxicity, Immunologic/genetics , Dendritic Cells/immunology , Immunotherapy, Adoptive , Interferon-gamma/metabolism , Lymphocyte Activation/genetics , Proteins/genetics , T-Lymphocytes, Cytotoxic/immunology , Transduction, Genetic , Transgenes/genetics , Biomarkers, Tumor/immunology
3.
Experimental & Molecular Medicine ; : 759-767, 2010.
Article in English | WPRIM | ID: wpr-122640

ABSTRACT

The abnormality of serine/threonine kinase Aurora-A is seen in many types of cancers. Although in physiological context it has been shown to play a vital role in cellular mitosis, how this oncogene contributes to tumorigenesis remains unclear. Here we demonstrate that Aurora-A overexpression enhances both the expression level and transcriptional activity of c-Myc. The inhibition of c-Myc expression by RNA interference significantly impaired the oncogenic potential of Aurora-A, resulting in attenuated cellular proliferation and transformation rates as well as fewer centrosomal aberrations. Furthermore, downregulation of c-Myc effectively overcame Aurora-A-induced resistance to cisplatin in esophageal cancer cells. Taken together, our results suggest an important role for c-Myc in mediating the oncogenic activity of Aurora-A, which may in turn allow for future targeting of c-Myc as a potential therapeutic strategy for tumors with Aurora-A overexpression.


Subject(s)
Humans , Cell Line, Transformed , Cell Proliferation/drug effects , Cell Transformation, Neoplastic/drug effects , Cisplatin/pharmacology , Down-Regulation , Gene Expression Regulation, Neoplastic/drug effects , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins c-myc/genetics , RNA, Small Interfering/genetics , Transcriptional Activation , Transgenes/genetics
4.
Mem. Inst. Oswaldo Cruz ; 104(3): 399-410, May 2009. ilus
Article in English | LILACS | ID: lil-517020

ABSTRACT

Amplicons are defective and non-integrative vectors derived from herpes simplex virus type 1. As the vector genome carries no virus genes, amplicons are both non-toxic for the infected cells and non-pathogenic for the inoculated organisms. In addition, the large transgenic capacity of amplicons, which allow delivery of up to 150 Kbp of foreign DNA, makes these vectors one of the most powerful, interesting and versatile gene delivery platforms. We present here recent technological developments that have significantly improved and extended the use of amplicons, both in cultured cells and in living organisms. In addition, this review also discusses the many difficulties still pending to be solved, in order to achieve stable and physiologically regulated transgene expression.


Subject(s)
Animals , Humans , Gene Transfer Techniques , Genetic Vectors/genetics , Herpesvirus 1, Human/genetics , Transgenes/genetics , Genetic Engineering , Herpesvirus 1, Human/physiology
5.
Experimental & Molecular Medicine ; : 84-96, 2007.
Article in English | WPRIM | ID: wpr-37552

ABSTRACT

Various cell types in higher multicellular organisms are genetically homogenous, but are functionally and morphologically heterogeneous due to the differential expression of genes during development, which appears to be controlled by epigenetic mechanisms. However, the exact molecular mechanisms that govern the tissue-specific gene expression are poorly understood. Here, we show that dynamic changes in histone modifications and DNA methylation in the upstream coding region of a gene containing the transcription initiation site determine the tissue-specific gene expression pattern. The tissue-specific expression of the transgene correlated with DNA demethylation at specific CpG sites as well as significant changes in histone modifications from a low ratio of methylated H3- lysine 4 or acetylated H3-lysine 9, 14 to acetylated H4 to higher ratios. Based on the programmed status of transgene silenced in cloned mammalian ear-derived fibroblasts, the transgene could be reprogrammed by change of histone modification and DNA methylation by inhibiting both histone deacetylase and DNA methylation, resulting in high expression of the transgene. These findings indicate that dynamic change of histone modification and DNA methylation is potentially important in the establishment and maintenance of tissue-specific gene expression.


Subject(s)
Animals , Transgenes/genetics , Swine , Organ Specificity/genetics , Methylation , Lysine/metabolism , Histones/metabolism , Histone Deacetylases/metabolism , Gene Silencing , Gene Expression , Fibroblasts , Ear , DNA Methylation , Cells, Cultured , Animals, Genetically Modified , Acetylation
6.
Experimental & Molecular Medicine ; : 196-202, 2006.
Article in English | WPRIM | ID: wpr-96572

ABSTRACT

We previously reported that transgenic mice produced with a transgene consisting of the SV40 T antigen and vasopressin without the 3'-flanking region exhibit brain tumors and lymphoma. In this study, transgenic mice were produced with the fusion gene containing the SV40 T antigen and the whole vasopressin gene with the 3'-flanking region. Six transgenic mice were generated, five which died after 2-6 weeks. The remaining founder mouse was investigated for fusion gene expression and tumor progression at the age of 6 weeks. Brain tumor cells were characterized for phenotypes and transgene expression. During in vitro cell cultures, the phenotypic appearances at 10, 20, and 30 passages were as a uniform monolayer with similar growth rates. The site of SV40 T antigen integration was in the A2 region of chromosome 11, and SV40 T antigen was expressed at the same level in cells of both earlier and later passages. Thirty passages were probably insufficient to reach crisis and immortalization. These cells enriched brain tumor cell compositions with astrocytes and neuronal cells.


Subject(s)
Mice , Animals , Vasopressins/genetics , Transgenes/genetics , Recombinant Fusion Proteins/genetics , Plasmids/genetics , Mice, Transgenic , Mice, Inbred ICR , In Situ Hybridization, Fluorescence/methods , Immunoenzyme Techniques , Gene Expression/genetics , Cell Proliferation , Cell Line, Tumor , Brain Neoplasms/genetics , Blotting, Western , Antigens, Polyomavirus Transforming/genetics
7.
Genet. mol. res. (Online) ; 4(2): 177-184, 30 jun. 2005. ilus, graf
Article in English | LILACS | ID: lil-445294

ABSTRACT

Transgene elimination is a poorly studied phenomenon in plants. We made genetic and molecular studies of a transgenic dry bean line immune to bean golden mosaic geminivirus and a soybean line. In both lines, the transgenes were stable during the vegetative phase but were eliminated during meiosis. Due to its potential biotechnological value, this transgenic line was micropropagated by grafting and the vegetative copies were studied for more than two years. More than 300 plants of progeny were obtained during this period, demonstrating that the phenomenon of elimination was consistently repeated and offering an opportunity for detailed study of transgene elimination, including the characterization of the integration sites. Cloning and sequencing of the transgenic loci, reciprocal crosses to untransformed plants, genomic DNA blots, and GUS assays were performed in the transgenic lines. Based on the molecular and genetic characterization, possible mechanisms involved in transgene elimination include intrachromosomal recombination, genetic instability resulting from the tissue culture manipulations, and co-elimination of transgenes, triggered by a process of genome defense.


Subject(s)
Soybeans/genetics , Phaseolus/genetics , Plants, Genetically Modified/genetics , Transgenes/genetics , Mosaic Viruses , DNA, Plant , Gene Deletion , Soybeans/virology , Phaseolus/virology , Polymerase Chain Reaction , Genetic Vectors/genetics
8.
Genet. mol. res. (Online) ; 4(4): 812-821, 2005. tab, ilus
Article in English | LILACS | ID: lil-444840

ABSTRACT

Transgenesis in cattle has provided numerous opportunities for livestock production. The development of nuclear transfer (NT) technology has improved the production of transgenic livestock. However, the isolation of pure colonies from a single transfection event remains laborious and can be a constraint in the production of transgenic livestock. We used 96-well cell culture plates to isolate cell lineages obtained from a single fibroblast transfected with the pCi-Neo plasmid. Since single mammalian cells do not grow well in fresh medium, we evaluated the use of conditioned medium. The neomycin phosphotransferase gene was detected in isolated colonies and NT embryos were produced from these cells. Multiplex-PCR assays were performed to detect the transfected fragment as well as autosomal satellite DNA in single NT embryos. This approach provided a reliable method for isolating transfected mammalian cells and for diagnosing the incorporation of desirable vectors in NT embryos. This method can reduce the time and cost of transgenic livestock production.


Subject(s)
Animals , Animals, Genetically Modified/genetics , Cattle/genetics , Transgenes/genetics , Nuclear Transfer Techniques , Animals, Genetically Modified/embryology , Cattle/embryology , Fibroblasts/cytology , Cell Nucleus/genetics
9.
Experimental & Molecular Medicine ; : 447-456, 2005.
Article in English | WPRIM | ID: wpr-207075

ABSTRACT

We investigated expression profiles and biological effects of the naked DNA vectors in the heart. To this end, naked DNA vector was injected into the apex of the beating rat heart after thorocotomy. When the expression of LacZ reporter was examined by reverse transcription-PCR and histochemical staining for b-galactosidase, LacZ expression was detected only in the heart, suggesting limited dissemination of the injected vector in vivo. Even within the heart, LacZ expression was limited to the injection area (apex). Similar observations were made with other transgenes such as VEGF and basic fibroblast growth factor (bFGF), where 77% and 69% of the total transgene exprssion were detected in the heart segments containing the apex. Although VEGF and bFGF expressions were detected until 2 weeks after DNA injection, the highest levels of VEGF and bFGF were observed on day 5 and day 1, respectively. The optimal doses of the vectors were 10 mg and 25 mg for the VEGF and bFGF vectors, respectively. Interestingly, injection of bFGF vector led to 50% increase in the level of endogenous murine VEGF expression. Consistent with this finding, the number of vessels that stained positive for alpha-smooth muscle actin was increased in the bFGF vector-injected heart. These results suggest that simple injection of naked DNA vector may be sufficient to induce significant angiogenesis in the myocardium and that naked DNA gene therapy may be a feasible approach for the treatment of ischemic heart disease.


Subject(s)
Animals , Male , Rats , Coronary Vessels/metabolism , DNA/genetics , Fibroblast Growth Factor 2/genetics , Gene Expression Profiling/methods , Gene Expression Regulation , Genes, Reporter/genetics , Genetic Vectors/genetics , Lac Operon/genetics , Myocardium/metabolism , Rats, Sprague-Dawley , Time Factors , Transgenes/genetics , Vascular Endothelial Growth Factor A/genetics
10.
Genet. mol. res. (Online) ; 3(4): 456-462, 2004. tab, graf
Article in English | LILACS | ID: lil-410890

ABSTRACT

Inducible transgenic mouse models that impose a constraint on both temporal and spatial expression of a given transgene are invaluable. These animals facilitate experiments that can address the role of a specific cell or group of cells within an animal or in a particular window of time. A common approach to achieve inducibility involves the site-specific recombinase ‘Cre’, which is linked to a modified version of one of various steroid hormone-binding domains. Thus, the expression of Cre is regulated such that a functional nuclear transgene product can only be generated with the addition of an exogenous ligand. However, critical requirements of this system are that the nuclear localization of the transgene product be tightly regulated, that the dosage of the inducing agent remains consistent among experimental animals and that the transgene cassette cannot express in the absence of the inducing agent. We used the Cre ER(T2) cassette, which is regulated by the addition of the estrogen antagonist tamoxifen to determine whether cross-contamination of tamoxifen between animals housed together can be a significant source of spurious results. We found that cross-contamination of exogenous tamoxifen does occur. It occurred in all animals tested. We suggest that the mechanism of contamination is through exposure to tamoxifen in the general environment and/or to coprophagous behavior. These results have important implications for the interpretation and design of experiments that use ‘inducible’ transgenic animals.


Subject(s)
Animals , Mice , Gene Expression Regulation, Enzymologic , Selective Estrogen Receptor Modulators/pharmacology , Tamoxifen/pharmacology , Transgenes/drug effects , Viral Proteins/genetics , Flow Cytometry , Mice, Transgenic , Recombinant Fusion Proteins/drug effects , Recombinant Fusion Proteins/genetics , Tail/drug effects , Tail/pathology , Transgenes/genetics , Viral Proteins/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL